CN101431996A - 蛋白质异戊二烯基转移酶的抑制剂 - Google Patents

蛋白质异戊二烯基转移酶的抑制剂 Download PDF

Info

Publication number
CN101431996A
CN101431996A CNA2007800144909A CN200780014490A CN101431996A CN 101431996 A CN101431996 A CN 101431996A CN A2007800144909 A CNA2007800144909 A CN A2007800144909A CN 200780014490 A CN200780014490 A CN 200780014490A CN 101431996 A CN101431996 A CN 101431996A
Authority
CN
China
Prior art keywords
compound
compounds
salt
cancer
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2007800144909A
Other languages
English (en)
Chinese (zh)
Inventor
玉野井冬彦
权五铉
渡边胜
汉娜·斐济
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California, San Diego
Original Assignee
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, San Diego filed Critical University of California, San Diego
Publication of CN101431996A publication Critical patent/CN101431996A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/96—Sulfur atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
CNA2007800144909A 2006-03-22 2007-03-22 蛋白质异戊二烯基转移酶的抑制剂 Pending CN101431996A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78444306P 2006-03-22 2006-03-22
US60/784,443 2006-03-22

Publications (1)

Publication Number Publication Date
CN101431996A true CN101431996A (zh) 2009-05-13

Family

ID=38541651

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2007800144909A Pending CN101431996A (zh) 2006-03-22 2007-03-22 蛋白质异戊二烯基转移酶的抑制剂

Country Status (7)

Country Link
US (1) US8093274B2 (enExample)
EP (1) EP2007383A4 (enExample)
JP (1) JP2009530392A (enExample)
CN (1) CN101431996A (enExample)
AU (1) AU2007229457A1 (enExample)
CA (1) CA2647038A1 (enExample)
WO (1) WO2007111948A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112574041A (zh) * 2020-12-25 2021-03-30 温州大学新材料与产业技术研究院 一种手性β羟基1,3-二羰基类化合物的合成方法

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
SG171690A1 (en) 2005-03-22 2011-06-29 Harvard College Treatment of protein degradation disorders
WO2008091349A1 (en) 2006-02-14 2008-07-31 The President And Fellows Of Harvard College Bifunctional histone deacetylase inhibitors
CA2647038A1 (en) 2006-03-22 2007-10-04 The Regents Of The University Of California Inhibitors of protein prenyltransferases
WO2007130429A2 (en) * 2006-05-03 2007-11-15 The President And Fellows Of Harvard College Histone deacetylase and tubulin deacetylase inhibitors
EP2321264B1 (en) 2008-07-23 2016-05-04 President and Fellows of Harvard College Deacetylase inhibitors and uses thereof
WO2010014054A1 (en) 2008-07-28 2010-02-04 The Regents Of The University Of California Inhibitors of protein prenyltransferases
US9125821B2 (en) 2008-07-28 2015-09-08 The Regents Of The University Of California Nanodrug targeting protein geranylgeranylation
US8716344B2 (en) 2009-08-11 2014-05-06 President And Fellows Of Harvard College Class- and isoform-specific HDAC inhibitors and uses thereof
WO2012097371A2 (en) * 2011-01-14 2012-07-19 The Regents Of The University Of California Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis
WO2012116181A2 (en) * 2011-02-24 2012-08-30 The Regents Of The University Of California Small molecules for endothelial cell activation
DK2707031T3 (da) 2011-05-08 2019-10-07 Legochem Biosciences Inc Protein-active agent conjugates and method for preparing the same
WO2013155223A1 (en) * 2012-04-10 2013-10-17 The Regents Of The University Of California Compositions and methods for treating cancer
EP3698797A1 (en) 2017-10-16 2020-08-26 Tsinghua University Mevalonic acid pathway inhibitor and pharmaceutical composition thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) * 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) * 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) * 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) * 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) * 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
AU2003259717A1 (en) 2002-08-07 2004-02-25 Bristol-Myers Squibb Company Modulators of rabggt and methods of use thereof
JP2006527756A (ja) * 2003-06-19 2006-12-07 ファイザー・プロダクツ・インク Ｎｋ１拮抗薬
CA2647038A1 (en) 2006-03-22 2007-10-04 The Regents Of The University Of California Inhibitors of protein prenyltransferases

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112574041A (zh) * 2020-12-25 2021-03-30 温州大学新材料与产业技术研究院 一种手性β羟基1,3-二羰基类化合物的合成方法

Also Published As

Publication number Publication date
WO2007111948A3 (en) 2008-08-07
US8093274B2 (en) 2012-01-10
CA2647038A1 (en) 2007-10-04
WO2007111948A2 (en) 2007-10-04
EP2007383A4 (en) 2010-09-15
US20100063114A1 (en) 2010-03-11
EP2007383A2 (en) 2008-12-31
JP2009530392A (ja) 2009-08-27
AU2007229457A1 (en) 2007-10-04

Similar Documents

Publication Publication Date Title
US8093274B2 (en) Inhibitors of protein prenyltransferases
US8815935B2 (en) Inhibitors of protein prenyltransferases
Hafez et al. Novel benzothiazole derivatives as multitargeted-directed ligands for the treatment of Alzheimer’s disease
EP3529240B1 (en) Pharmaceutical compounds
WO2011044073A1 (en) Pyrrolidine gpr40 modulators
US8404738B2 (en) 4-amino-N-hydroxy-benzamides for the treatment of cancer
US9365558B2 (en) Dihydropyridinone MGAT2 inhibitors
AU2012345863A1 (en) Aryl dihydropyridinones and piperidinones as MGAT2 inhibitors
Mariaule et al. 3-Oxo-hexahydro-1 H-isoindole-4-carboxylic Acid as a Drug Chiral Bicyclic Scaffold: Structure-Based Design and Preparation of Conformationally Constrained Covalent and Noncovalent Prolyl Oligopeptidase Inhibitors
Bajda et al. Novel carbamate derivatives as selective butyrylcholinesterase inhibitors
US20210002214A1 (en) Phenyl cyclohexanone derivatives and methods of making and using them
AU2019242518A1 (en) Compound with anticancer activity
Chamakuri et al. Synthesis of enantiomerically pure 6-substituted-piperazine-2-acetic acid esters as intermediates for library production
Alkubaisi et al. Complexity‐To‐Diversity and Pseudo‐Natural Product Strategies as Powerful Platforms for Deciphering Next‐Generation Therapeutics
Reddy et al. HDAC and NF-κB mediated cytotoxicity induced by novel N-Chloro β-lactams and benzisoxazole derivatives
Hekking et al. Development of potent Mcl-1 inhibitors: Structural investigations on macrocycles originating from a DNA-encoded chemical library screen
Ghosh et al. Synthesis and evaluation of 9-epi-Koshidacin B as selective inhibitor of histone deacetylase 1
Oliveira et al. Synthesis and pharmacological evaluation of novel isoquinoline N-sulphonylhydrazones designed as ROCK inhibitors
EP2280940A1 (en) Novel n-(2-amino-phenyl)-acrylamides
WO2010031708A2 (en) Novel ortho-aminoanilides for the treatment of cancer
CN122070289A (zh) 羟基去甲氯胺酮类似物及其用途
Johnston et al. Transcriptomic Signature and PROTAC Strategy Revealed Histone Lysine Demethylase as a Target of Anticancer Activity of Deferiprone
Nepomuceno Studies Toward the Total Synthesis of a Natural Product and Exploration of the Chemical Biology of the Bacterial Cell Division Protein FtsZ
Liu Novel concepts and methodologies in pseudo natural product chemistry
Cao et al. Identification of Novel β‐Lactam Derivatives as Proteasome Inhibitors for Antitumor Therapy

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20090513